Press Releases

Thermo Fisher Scientific to Showcase New Mass Spectrometry Instruments and Software Solutions During Virtual Events

Thermo Fisher Scientific Inc., the world leader in serving science, will provide online programming and virtual exhibits to introduce scientists to a number of new products that build on its leading Orbitrap platform and expand research applications. The company...

Serialization: Syntegon joins OPEN-SCS Group

Syntegon Technology recently joined the Open Serialization Communication Standard (OPEN-SCS) Group. Joint goals include the fight against pharmaceutical counterfeiting and the establishment of interoperable interfaces for the implementation of adequate serialization solutions. Open platforms are the future The OPEN-SCS Group was...

CPhI Worldwide 2020 Implements new ‘Informa AllSecure Standard’

CPhI Worldwide – organised by Informa Markets – will this year be organised in accordance with Informa’s AllSecure health and safety standard in response to COVID-19. As a leading events’ organiser, Informa has developed a detailed set of measures...

Greenphire Launches New Clinical Trial Budget Build and Negotiation Solution, EnvisiX

Greenphire, the global leader in financial lifecycle management for clinical trials, announced the launch of EnvisiX to address the budgeting challenges experienced by global sponsors and CROs during study start-up. The new budget development solution streamlines trial initiation for...

AbbVie Submits Regulatory Applications to FDA and EMA for RINVOQ for the Treatment of Adults with Active Psoriatic Arthritis

AbbVie , a research-based global biopharmaceutical company, announced that it has submitted applications for a new indication to the U.S. FDA and European Medicines Agency (EMA) for RINVOQ (upadacitinib; 15 mg, once daily), a selective and reversible JAK inhibitor,...

Daiichi Sankyo and Syneos Health Form Strategic Coalition for Development of Daiichi Sankyo’s ADC Oncology Pipeline

Daiichi Sankyo, Inc. announced that it has entered into a strategic agreement with Syneos Health The companies are coming together to form a coalition to accomplish their shared goal of bringing promising cancer therapies to patients as safely, effectively...

Merck, Junshi Biosciences collaborate to explore head, neck cancer treatment

Junshi Biosciences , a China-based biopharmaceutical company specializing in discovery, development and commercialization of novel therapies, and Merck, a world leading science and technology company, announced their collaboration on a clinical trial program designed to investigate the efficacy and...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read